zolbetuximab
astellas
[]
 spotlight: cldn18.2 mab zolbetuximab + mfolfox showed superior pfs and os compared to placebo + placebo in cldn18.2 high (75%+ staining) met #gastriccancer and #gejcancer #gi23 
GI Medical Oncologist, Associate Professor of Medicine @Georgetown @RueschCenter @LombardiCancer, Ex-@SidwellFriends @Penn @KeckMedUSC keyboardist @BasementRiot